Project Profile

A Phase 1, Open label, Dose-ranging Study to Assess the Safety, Tolerability, Preliminary Efficacy, and Dose Effect of CFL001 Cord Blood Product in Patients with Symptomatic Sacroiliac Joint (SIJ) Syndrome - Services Agreement

Keyword Search